Abstract
The use of femoral artery closure devices to obtain hemostasis after percutaneous catheterization has become widespread because of their proven feasibility in combination with patient-related advantages. Since 2002 more than 6,500 patients have undergone either diagnostic angiography or therapeutic intervention via the femoral route with an Angioseal closure device in our hospital. We were faced with six cases of limb-threatening complications, which are described here. Most (5/6) complications were of obstructive origin due to traumatic dissection or occlusion of the artery mainly caused by malpositioning of the device. Recommendations are made in order to prevent or successfully overcome this certainly increasing problem in the vascular field.
This is a preview of subscription content, log in via an institution to check access.
References
Aker UT, Kensey KR, Heuser RR, Sandza JG, Kussmaul WG III. Immediate arterial hemostasis after cardiac catheterization: initial experience with a new puncture closure device. Cathet Cardiovasc Diagn 1994;31:228–232
Kussmaul WG III, Buchbinder M, Whitlow PL, et al. Rapid arterial hemostasis and decreased access site complications after cardiac catheterization and angioplasty: results of a randomized trial of a novel hemostatic device. J Am Coll Cardiol 1995;25:1685–1692
Resnic FS, Blake GJ, Ohno-Machado L, et al. Vascular closure devices and the risk of vascular complications after percutaneous coronary intervention in patients receiving glycoprotein IIb-IIIa inhibitors. Am J Cardiol 2001;88:493–496
Sanborn TA, Biggs HH, Brinker JA, Knopf WD, Kosinski EJ, Roubin GS. A multicenter randomized trial comparing a percutaneous collagen hemostasis device with conventional manual compression after diagnostic angiography and angioplasty. J Am Coll Cardiol 1993;22:1273–1279
Heintzen MP, Straure BE. Peripheral arterial complications after heart catheterization. Herz 1998;23:4–20
Koreny M, Riedmuller E, Nikfardjam M, Siostrzonek P, Mullner M. Arterial puncture closing devices compared with standard manual compression after cardiac catheterization. J A M A 2004;291:350–357
Carey D, Martin JR, Moore CA, Valentine MC, Nygaard ThW. Complications of femoral artery closure devices. Cathet Cardiovasc Intervent 2001;52:3–7
Lumdsen AB, Miller JM, Kosinski AS, et al. A prospective evaluation of surgically treated groin complications following percutaneous cardiac procedures. Am Surg 1994;60:132–137
Henry M, Amor M, Allaoui M, Tricoche O. A new access site management tool: the Angioseal hemostatic puncture closure device. J Endovasc Surg 1995;2:289–296
Cremonesi A, Castriota F, Tarantino F, et al. Femoral arterial hemostasis using the Angioseal system after coronary and vascular percutaneous angioplasty and stenting. J Invas Cardiol 1998;10:464–469
Shammas NW, Rajendran VR, Alldredge SG, et al. Randomized comparison of vasoseal and angioseal closure devices in patients undergoing coronary angiography and angioplasty. Catheter Cardiovasc Interv 2002;55:421–425
Abando A, Hood D, Weaver F, Katz S. The use of the Angioseal device for femoral artery closure. J Vasc Surg 2004;40:287–290
Shaw JA, Gravereaux EC, Winters GL, Eisenhauer AC. An unusual cause of claudication. Catheter Cardiovasc Interv 2003;60:562–565
Sprouse LR, Botta DM, Hamilton IN. The management of peripheral vascular complications associated with the use of percutaneous suture-mediated closure devices. J Vasc Surg 2001;33:688–693
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Wille, J., Vos, J.A., Overtoom, T.T. et al. Acute Leg Ischemia: The Dark Side of a Percutaneous Femoral Artery Closure Device. Ann Vasc Surg 20, 278–281 (2006). https://doi.org/10.1007/s10016-006-9005-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10016-006-9005-3